Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Managing Conflict in Organisations: Have you enough of the right kind

Michael O’Neill is a Biotech entrepreneur, currently R&D Director of his own company Inflection Biosciences. He is also a chartered psychologist and has worked as a consultant and technical and organisational issues in the biosciences industry for many years. He … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , | Leave a comment

Managing Conflict in Organisations: Part 2

Michael O’Neill is a Biotech entrepreneur, currently R&D Director of his own company Inflection Biosciences. He is also a chartered psychologist and has worked as a consultant and technical and organisational issues in the biosciences industry for many years. He … Continue reading

Posted in Pharmaceutical business | Tagged , , , | Leave a comment

U.S. and South Korean Firms Form Joint Venture

Sorrento Therapeutics, clinical-stage biopharmaceutical company in San Diego, and Yuhan Corporation, an established health care company based in Seoul, have entered into an agreement to form a joint venture, ImmuneOncia Therapeutics. The joint venture will develop and commercialise a number … Continue reading

Posted in Pharmaceutical business | Tagged , , | Leave a comment

Vertex and CRISPR Therapeutics Form Research Collaboration

BOSTON & CAMBRIDGE, Massachusetts – Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics have announced that the two companies have entered into a strategic research collaboration focused on the use of CRISPR’s gene editing technology, known as CRISPR-Cas9, to discover and develop potential … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

Psoriasis drug dropped by Amgen goes to Valeant

Valeant Pharmaceuticals is a very aggressive acquirer of companies and assets. The Canadian company has most recently purchased the rights to an asset from AstraZeneca in the area of psoriasis. The drug, brodalumab, was previously partnered with Amgen but the … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

MorphoSys partners to access GPCR-Targeting tech

MorphoSys based out of Munich and G7 Therapeutics AG of Zurich announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors (GPCRs) and potentially other disease-related transmembrane proteins such as ion channels. … Continue reading

Posted in Pharmaceutical business | Tagged , , , , | Leave a comment

Women Currently only 10% of Biotech Boards, Gender Study Shows

Authored by Karl Simpson In a new research study into gender diversity in biotech leadership, the findings convey a picture of significant male dominance in biotech boardroom. The research conducted by Liftstream, a specialist life sciences executive search practice, examined … Continue reading

Posted in Executive Appointments, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Sutro Biopharma signs $1bn deal with Celgene

Authored by James Sheppard The San Francisco based biotech company Sutro Biopharma announced that it has signed a multi-year strategic collaboration and option to acquire agreement with the global biotech company Celgene. The deal follows an agreement signed between the … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , | Leave a comment

Moderna Therapeutics partners with Karolinska Institutet

Authored by James Sheppard The world renowned Karolinska Institutet has partnered with the Cambridge based biotech Moderna Therapeutics to develop new messenger RNA therapeutics for a range of serious diseases. The partnership will see the establishment of a new company called … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

Prosensa begins FDA submission process for DMD drug

Authored by James Sheppard The Dutch biotechnology company Prosensa has announced that it has begun the submission process for its Duchenne Muscular Dystrophy (DMD) drug Drisapersen with the FDA. Prosensa has hoped that it will fully file by the year … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap